Trial N/A
Publication Liu K, Complement Ther Clin Pract, 2020
Funding: * ()
| Methods | |
| RCT | |
| Location :
Multicenter / China Follow-up duration (days): 42 | |
| Inclusion criteria | (1) with a definite diagnosis of COVID-19; (2)aged 65 years or above; (3) at least 6 months after the onset of other acutediseases; (4) mini-mental state examination (MMSE) score > 21; (6) noCOPD or any other respiratory disease; and (7) forced expiratory volumein 1 s (FEV1) at least 70%. |
| Exclusion criteria | (1) moderate or severe heartdisease (Grade III or IV, New York Heart Association); (2) with severeischemic or hemorrhagic stroke or neurodegenerative diseases. |
| Interventions | |
| Treatment
Respiratory rehabilitation (Once a day for 10 minutes (home ) Duration : 6 weeks |
|
| Control
No respiratory rehabilitation | |
| Participants | |
| Randomized 76 participants (n1=38 / n2= 38) | |
| Characteristics of participants N=76 Mean age : 69,2 49 males | |
| Primary outcome | |
| In the register NR | |
| In the report | |
| Documents available |
Protocol NR Statistical plan NR Data-sharing stated NR |
| Risk of bias Overall The overall risk of bias reported in the table corresponds to the highest risk of bias for the outcomes assessed for the systematic review |
High |
| General comment | The study registry, protocol and statistical analysis plan were not available. Whether randomization occured or not, and other information relevant to randomization (i.e., whether random allocation was concealed), is unclear. |